Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Express Scripts
Daiichi Sankyo
Medtronic
Dow
UBS
Deloitte
Chubb
US Department of Justice

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018922

« Back to Dashboard

NDA 018922 describes LODINE, which is a drug marketed by Wyeth Pharms Inc and is included in two NDAs. Additional details are available on the LODINE profile page.

The generic ingredient in LODINE is etodolac. There are twenty-three drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the etodolac profile page.
Summary for 018922
Tradename:LODINE
Applicant:Wyeth Pharms Inc
Ingredient:etodolac
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018922

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 31, 1991TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength300MG
Approval Date:Jan 31, 1991TE:RLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 29, 1993TE:RLD:Yes

Expired US Patents for NDA 018922

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc LODINE etodolac CAPSULE;ORAL 018922-002 Jan 31, 1991 ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc LODINE etodolac CAPSULE;ORAL 018922-003 Jan 31, 1991 ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc LODINE etodolac TABLET;ORAL 018922-004 Jul 29, 1993 ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc LODINE etodolac CAPSULE;ORAL 018922-002 Jan 31, 1991 ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc LODINE etodolac CAPSULE;ORAL 018922-003 Jan 31, 1991 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Express Scripts
Argus Health
Chinese Patent Office
Chubb
Moodys
Merck
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot